Adverse event | Low-dose group (n = 36) | Standard-dose group (n = 45) |
---|---|---|
Number of discontinued patients, n (%) | 3 (8.3) | 13 (28.9) |
Details of adverse events | ||
Fever, n (%) | 0 (0.0) | 5 (11.1) |
Rash, n (%) | 0 (0.0) | 6 (13.3) |
Anorexia, n (%) | 0 (0.0) | 2 (4.4) |
Thrombocytopenia, n (%) | 3 (8.3) | 6 (13.3) |
Leukocytopenia, n (%) | 3 (8.3) | 2 (4.4) |
Anemia, n (%) | 2 (5.6) | 6 (13.3) |
Hyperkalemia, n (%) | 1 (2.8) | 2 (4.5) |
Hyponatremia, n (%) | 2 (5.6) | 6 (13.3) |
Increased alanine aminotransferase, n (%) | 0 (0.0) | 5 (11.1) |
Increased aspartate aminotransferase, n (%) | 0 (0.0) | 5 (11.1) |